Implications for perioperative patient management
To Register for ACS 2025 please visit our new website at ACS 2025
Dave Story is Professor and Foundation Chair of Anaesthesia at the University of Melbourne and Head of the University Department of Critical Care. Prof Story is the current ANZCA President. His main research interest is clinical and cost-effective approaches to reduce perioperative risk, complications, disability, and mortality.
He also works as a staff Anaesthetist at the Austin Hospital where he provides perioperative care for most procedural specialties including liver transplantation. His love of the outdoors led to research in altitude physiology, subsequent Anaesthesia career, environmental advocacy, and recreational hiking and bike riding.
Dr Margarson trained in London, Oxford, Munich and Sydney and is currently Consultant in Anaesthesia and Critical Care, St Richard's Hospital, Chichester. He was a founder member of the UK Society for Obesity and Bariatric Anaesthesia (SOBA), is currently Vice-president for the European Society for the Peri-operative Care of the Obese Patient (ESPCOP), and active in the sub-committees of the Society for Anesthesia and Sleep Medicine.
His original research interest and MD thesis was on microvascular permeability and rates of transcapillary albumin escape in sepsis. Current interests are mainly focussed around the airway and dosing scalars in anaesthesia for the morbidly obese.
ACS is a one-day single theme meeting offering anaesthetists, intensivists and pain specialists an in-depth look at an area of rapidly changing clinical practice. The theme for ACS 2025 is Advances in Diabetes, Obesity and Metabolic Syndrome management.
Our keynote speakers are Professor David Story and Dr Michael Margarson.
Professor Story is the Foundation Chair of Anaesthesia at the University of Melbourne and Head of the University Department of Critical Care. He is the current ANZCA President. He will provide an update on the perioperative management of the patient with Diabetes.
Dr Michael Margarson is a Consultant Anaesthetist from Chichester in the UK who is currently on sabbatical to Royal Hobart Hospital in Tasmania. His interests include the anaesthetic management of the obese patient including drug dosing and airway management.
We also have talks on the medical and surgical management of morbid obesity, OSA and NASH.
| 0800 - 0825 | Opening and welcome | Peter Xiang |
| Session 1 - Diabetes management in 2025 | ||
| 0825 - 0855 | Drug treatment of DM and the value of preoperative HbA1c | Prof David Story |
| 0855 - 0915 | Outside the perioperative space: What's new in medical therapy for Type 2 Diabetes? | Prof Rinki Murphy |
| 0915 - 0935 | GLP1's and SGLT2's in perioperative DM management | Prof David Story |
| 0935 - 1005 | Case discussion | Panel |
| 1005 - 1035 | Morning Break | |
| Session 2 - Obesity Anaesthesia | ||
| 1055 - 1125 | Impact of GLP-1's on Obesity management | Prof Rinki Murphy |
| 1125 - 1155 | Current surgical management options in morbid obesity | Mr Michael Booth |
| 1155 - 1225 | Medical management and patient support in bariatric surgery | Dr Chaey Leem |
| 1225 - 1245 | Lessons from Bariatric Surgery: What have we learnt? | Dr Michael Booth |
| 1245 - 1330 | Lunch | |
| Session 3 - Anaesthesia for the Morbidly Obese | ||
| 1330 - 1400 | Anaesthesia drug dosing in obese patients | Dr Mike Margason |
| 1400 - 1425 | Airway management in morbid obesity | Dr Gemma Malpas |
| 1425 - 1455 | OSA and OHS in obesity | Dr Mike Margason |
| 1440 - 1500 | Panel discussion Q&A | |
| 1500 - 1530 | Afternoon break | |
| Session 4 - "Diabesity" Outcomes and Cases | ||
| 1530 - 1600 | Metabolic dysfunction associated liver diease | Dr Tom Fernandez |
| 1600 - 1655 | Obesity cases and Panel Q&A | Dr Liam O'Hara |
| 1655 - 1700 | Closing comments and future meetings | |
| 0800 - 0825 | Opening and welcome | Peter Xiang |
| Session 1 - Diabetes management in 2025 | ||
| 0825 - 0855 | Drug treatment of DM and the value of preoperative HbA1c | Prof David Story |
| 0855 - 0915 | Outside the perioperative space: What's new in medical therapy for Type 2 Diabetes? | Prof Rinki Murphy |
| 0915 - 0935 | GLP1's and SGLT2's in perioperative DM management | Prof David Story |
| 0935 - 1005 | Case discussion | Panel |
| 1005 - 1035 | Morning Break | |
| Session 2 - Obesity Anaesthesia | ||
| 1055 - 1125 | Impact of GLP-1's on Obesity management | Prof Rinki Murphy |
| 1125 - 1155 | Current surgical management options in morbid obesity | Mr Michael Booth |
| 1155 - 1225 | Medical management and patient support in bariatric surgery | Dr Chaey Leem |
| 1225 - 1245 | Lessons from Bariatric Surgery: What have we learnt? | Dr Michael Booth |
| 1245 - 1330 | Lunch | |
| Session 3 - Anaesthesia for the Morbidly Obese | ||
| 1330 - 1400 | Anaesthesia drug dosing in obese patients | Dr Mike Margason |
| 1400 - 1425 | Airway management in morbid obesity | Dr Gemma Malpas |
| 1425 - 1455 | OSA and OHS in obesity | Dr Mike Margason |
| 1440 - 1500 | Panel discussion Q&A | |
| 1500 - 1530 | Afternoon break | |
| Session 4 - "Diabesity" Outcomes and Cases | ||
| 1530 - 1600 | Metabolic dysfunction associated liver diease | Dr Tom Fernandez |
| 1600 - 1655 | Obesity cases and Panel Q&A | Dr Liam O'Hara |
| 1655 - 1700 | Closing comments and future meetings | |
Click on the icon below to open the abstract booklet
